I.G.G.M. Biltjes MD, P. Bracke MD, N. van den Eede MD, D. Verhoeven MD, PhD, S. Haegeman MD, W. Volders MD
Artificial intelligence (AI) is being rapidly introduced in the daily practice of the medical professions. Here, an AI algorithm specialised in the detection of suspicious breast lesions on 2D and DBT images was used. This is a product from RMS: iCAD-ProFound 2D-3D Mammography. The first experiences are now presented, highlighting the advantages and pitfalls of the system.
N. van den Eede MD, A. de Paepe MD, D. Strens MSc, P. Specenier MD, PhD
We calculated the management costs from diagnosis to death of glioblastoma patients treated at the Antwerp University Hospital between 2007 and 2016. Overall, the average cost per patient from the health care payer’s perspective was €45,165 (95% confidence interval €37,204–€54,104). The major cost driving factor was hospitalisation.